Skip to menu Skip to content Skip to footer
Associate Professor Henry Marshall
Associate Professor

Henry Marshall

Email: 

Overview

Background

Dr Henry Marshall is a Thoracic Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre. Dr Marshall's research interests are in lung cancer screening/early detection and smoking cessation. His PhD (UQ 2015) was based on the first trial of lung cancer screening in Australia. He is site PI for Australia's second screening trial, the International Lung Screen Trial.

Availability

Associate Professor Henry Marshall is:
Available for supervision

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Lung cancer screening

  • Smoking cessation

  • Artificial intelligence for medical imaging

  • Artificial intelligence for smoking cessation

  • Biomarkers for lung cancer

Research impacts

Lung cancer is the leading cause of cancer mortality in Australia and the world. Lung cancer screening can reduce mortality by detecting tumours early. Helping people quit smoking reduces future risk of cancer. The team at The Prince Charles Hospital and University of Queensland Thoracic Research Centre are internationally recognised, leading clinical research in lung cancer screening in Australia.

Works

Search Professor Henry Marshall’s works on UQ eSpace

169 works between 2002 and 2025

61 - 80 of 169 works

2023

Conference Publication

Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial

Cressman, Sonya, Weber, Marianne, Ngo, Preston, Tremblay, Alain, Wade, Stephen, Manser, Renee, Stone, Emily, Atkar-Khattra, Sukhinder, Karikios, Deme, Ho, Cheryl, Harpaz, Silvia Behar, Caruana, Michael, Fernandes, Aleisha, Weng, Jing Yi, McWilliams, Annette, Meyers, Renelle, Mayo, John, Yee, John, Yuan, Ren, Marshall, Henry, Fong, Kwun, Lam, Stephen, Canfell, Karen and Tammemagi, Martin (2023). Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial. HOBOKEN: WILEY.

Economics, equity and eligibility: Using risk models versus age-smoke history categorical criteria for selection to the international lung screening trial

2023

Conference Publication

Diagnostic performance of FDG-PET in screen detected lung cancers in the international lung screen trial

McWilliams, Annette, Logan, Jacqueline, Brims, Fraser, Marshall, Henry, Passmore, Linda, Page, Barbara, Stone, Emily, Manser, Renee, Fogarty, Paul, Atkar-Khattra, Sukhinder, Myers, Renelle, Fong, Kwun and Lam, Stephen (2023). Diagnostic performance of FDG-PET in screen detected lung cancers in the international lung screen trial. Australian Lung Cancer Conference 2023, Gold Coast, QLD, Australia, 15 - 17 February 2023. Hoboken, NJ, United States: Wiley.

Diagnostic performance of FDG-PET in screen detected lung cancers in the international lung screen trial

2023

Conference Publication

Personalised risk categorisation of participants at screening entry in the international lung screen trial

McWilliams, Annette, Logan, Jacqueline, Brims, Fraser, Marshall, Henry, Passmore, Linda, Page, Barbara, Stone, Emily, Manser, Renee, Fogarty, Paul, Parsons, Sriyani, Atkar-Khattra, Sukhinder, Cressman, Sonya, Myers, Renelle, Tammemagi, Martin, Weber, Marianne, Canfell, Karen, Fong, Kwun and Lam, Stephen (2023). Personalised risk categorisation of participants at screening entry in the international lung screen trial. Australian Lung Cancer Conference 2023, Gold Coast, QLD, Australia, 15 - 17 February 2023. Hoboken, NJ, United States: Wiley.

Personalised risk categorisation of participants at screening entry in the international lung screen trial

2023

Conference Publication

Twenty years of progress; the Prince Charles hospital lung bank and its role in advancing lung cancer laboratory, clinical and molecular research

Chee, Kelly Tian Mun, Martins, Maria, Goldsworthy, Anita, Hollan, Melanie, Courtney, Deborah, Passmore, Linda, Brady, Jaccalyne, Mccaul, Elizabeth, Duhig, Edwina, Clarke, Belinda, Godbolt, David, Page, Barbara, Davidson, Morgan, Tran, Kayla, Pauli, John, Manawar, Sheyna, Gupta, Shilpi, Windsor, Morgan, Naidoo, Rishen, Bowman, Raylee, Marshall, Henry, Yang, Ian and Fong, Kwun (2023). Twenty years of progress; the Prince Charles hospital lung bank and its role in advancing lung cancer laboratory, clinical and molecular research. Australian Lung Cancer Conference 2023, Gold Coast, QLD, Australia, 15 - 17 February 2023. Richmond, VIC, Australia: John Wiley & Sons.

Twenty years of progress; the Prince Charles hospital lung bank and its role in advancing lung cancer laboratory, clinical and molecular research

2023

Conference Publication

Biomarkers of lung cancer in never-smokers: Current evidence

Stephens, Edward, Guayco, Jazmin, Lopez-Loo, Kenneth, Marshall, Henry, Yang, Ian and Fong, Kwun (2023). Biomarkers of lung cancer in never-smokers: Current evidence. Australian Lung Cancer Conference 2023, Gold Coast, QLD Australia, 15 - 17 February 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14471

Biomarkers of lung cancer in never-smokers: Current evidence

2023

Conference Publication

Australians interested in the international lung screen trial of lung cancer screening and their PLCOm2012 lung cancer risk factor model prediction

Fong, Kwun, McWilliams, Annette, Brims, Fraser, Stone, Emily, Manser, Renee, Fogarty, Paul, Passmore, Linda, Logan, Jacquieline, Brady, Jacci, Atkar-Khattra, Sukhinder, Myers, Renelle, Lam, Stephen, Tammemagi, Martin, Yang, Ian and Marshall, Henry (2023). Australians interested in the international lung screen trial of lung cancer screening and their PLCOm2012 lung cancer risk factor model prediction. HOBOKEN: WILEY.

Australians interested in the international lung screen trial of lung cancer screening and their PLCOm2012 lung cancer risk factor model prediction

2023

Conference Publication

Comparison of twelve lung cancer prediction scores on baseline CT scan in a lung cancer screening cohort

Dawkins, Paul, Marshall, Henry, Coomarasamy, Christin, Passmore, Linda, Page, Barbara and Fong, Kwun (2023). Comparison of twelve lung cancer prediction scores on baseline CT scan in a lung cancer screening cohort. Australian Lung Cancer Conference 2023, Gold Coast, QLD, Australia, 15 - 17 February 2023. Hoboken, NJ, United States: Wiley.

Comparison of twelve lung cancer prediction scores on baseline CT scan in a lung cancer screening cohort

2023

Conference Publication

Biomarkers for lung cancer screening-Systematic review

Guayco, Jazmin, Stephens, Edward, Lopez-Loo, Kenneth, Marshall, Henry, Yang, Ian and Fong, Kwun (2023). Biomarkers for lung cancer screening-Systematic review. Australian Lung Cancer Conference 2023, Gold Coast, QLD Australia, 15 - 17 February 2023. Richmond, VIC Australia: John Wiley and Sons. doi: 10.1111/resp.14471

Biomarkers for lung cancer screening-Systematic review

2023

Conference Publication

Lung cancer risk in Quitline clients

Marshall, Henry, Isbel, Joanne, Peardon-Freeman, Shelley and Fong, Kwun (2023). Lung cancer risk in Quitline clients. HOBOKEN: WILEY.

Lung cancer risk in Quitline clients

2023

Conference Publication

Physical activity levels of people at high risk for lung cancer: An observational study

Bonney, Asha, Granger, Catherine, Lin, Linda, Li, Jiashi, Pang, Siyuan, Irving, Louis, Steinfort, Daniel, Marshall, Henry, Fong, Kwun and Manser, Renee (2023). Physical activity levels of people at high risk for lung cancer: An observational study. HOBOKEN: WILEY.

Physical activity levels of people at high risk for lung cancer: An observational study

2023

Journal Article

A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: the Lung cancer Evaluation And Policy program (LEAPp)

Vaneckova, Pavla, Wade, Stephen, Caruana, Michael, Ngo, Preston, Behar Harpaz, Silvia, Sarich, Peter, Luo, Qingwei, Goldsbury, David Eamon, Cheng, Elvin, Yu, Xue Qin, Watts, Christina, Barron, Katherine, Yap, Mei Ling, Grogan, Paul Bernard, Banks, Emily, Fong, Kwun Meng, Marshall, Henry, Karikios, Deme, Rankin, Nicole Marion, Tammemägi, Martin Carl, McWilliams, Annette, Cressman, Sonya, Canfell, Karen and Weber, Marianne Frances (2023). A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: the Lung cancer Evaluation And Policy program (LEAPp). Annals of Cancer Epidemiology, 7, 1-17. doi: 10.21037/ace-22-11

A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: the Lung cancer Evaluation And Policy program (LEAPp)

2023

Conference Publication

A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The LEAPp program

Vaneckova, Pavla, Wade, Stephen, Caruana, Michael, Ngo, Preston, Harpaz, Silvia Behar, Sarich, Peter, Luo, Qingwei, Goldsbury, David, Cheng, Elvin, Yu, Xue Qin, Barron, Katherine, Yap, Mei Ling, Grogan, Paul, Banks, Emily, Fong, Kwung, Marshall, Henry, Karikios, Deme, Rankin, Nicole, Cressman, Sonya, Tammemagi, Martin, McWilliams, Annette, Weber, Marianne and Canfell, Karen (2023). A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The LEAPp program. HOBOKEN: WILEY.

A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The LEAPp program

2023

Conference Publication

Development of an Australia and New Zealand lung cancer clinical quality registry: A protocol paper

Smith, Shantelle, Harden, Susan, Briggs, Lisa, Leigh, Lillian, Brims, Fraser, Brooke, Mark, Brunelli, Vanessa, Chia, Collin, Dawkins, Paul, Lawrenson, Ross, Duffy, Mary, Evans, Sue, Leong, Tracy, Marshall, Henry, Patel, Dainik, Pavlakis, Nick, Philip, Jennifer, Rankin, Nicole, Singhal, Nimit, Stone, Emily, Tay, Rebecca, Vinod, Shalini, Windsor, Morgan, Wright, Gavin, Leong, David, Zalcberg, John and Stirling, Rob (2023). Development of an Australia and New Zealand lung cancer clinical quality registry: A protocol paper. HOBOKEN: WILEY.

Development of an Australia and New Zealand lung cancer clinical quality registry: A protocol paper

2023

Conference Publication

Smoking cessation, quit attempts and smoking cessation interventions in a cohort undergoing lung cancer screening in the international lung screen trial

Kung, Samantha, Fong, Kwun, Yang, Ian, Brady, Jaccalyne, Passmore, Linda and Marshall, Henry (2023). Smoking cessation, quit attempts and smoking cessation interventions in a cohort undergoing lung cancer screening in the international lung screen trial. HOBOKEN: WILEY.

Smoking cessation, quit attempts and smoking cessation interventions in a cohort undergoing lung cancer screening in the international lung screen trial

2023

Journal Article

Air pollution and lung cancer—A new era

Stephens, Edward K. H., Marshall, Henry M., Chin, Venessa and Fong, Kwun M. (2023). Air pollution and lung cancer—A new era. Respirology, 28 (4), 313-315. doi: 10.1111/resp.14464

Air pollution and lung cancer—A new era

2023

Journal Article

The tobacco endgame for the Asia Pacific

Marshall, Henry M., Gartner, Coral E. and Fong, Kwun M. (2023). The tobacco endgame for the Asia Pacific. Respirology, 28 (4), 309-312. doi: 10.1111/resp.14465

The tobacco endgame for the Asia Pacific

2023

Journal Article

Economic impact of using risk models for eligibility selection to the International lung screening Trial

Cressman, Sonya, Weber, Marianne F., Ngo, Preston J., Wade, Stephen, Behar Harpaz, Silvia, Caruana, Michael, Tremblay, Alain, Manser, Renee, Stone, Emily, Atkar-Khattra, Sukhinder, Karikios, Deme, Ho, Cheryl, Fernandes, Aleisha, Yi Weng, Jing, McWilliams, Annette, Myers, Renelle, Mayo, John, Yee, John, Yuan, Ren, Marshall, Henry M., Fong, Kwun M., Lam, Stephen, Canfell, Karen and Tammemägi, Martin C. (2023). Economic impact of using risk models for eligibility selection to the International lung screening Trial. Lung Cancer, 176, 38-45. doi: 10.1016/j.lungcan.2022.12.011

Economic impact of using risk models for eligibility selection to the International lung screening Trial

2022

Book Chapter

COPD: the risk of cancer and the impact on cancer care

Yang, Ian A., Shaw, Janet G., Stephens, Edward K.H., Chee, Tian Mun, Duhig, Edwina E., Bowman, Rayleen V., Olive, Gerard N., Marshall, Henry M. and Fong, Kwun M. (2022). COPD: the risk of cancer and the impact on cancer care. Lung diseases and cancer. (pp. 91-104) edited by Peter M.A. Calverley, Miguel Ángel Martínez-García, Mina Gaga and Kwun M. Fong. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/2312508x.10018721

COPD: the risk of cancer and the impact on cancer care

2022

Journal Article

Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

Behar Harpaz, Silvia, Weber, Marianne F., Wade, Stephen, Ngo, Preston J., Vaneckova, Pavla, Sarich, Peter E. A., Cressman, Sonya, Tammemagi, Martin C., Fong, Kwun, Marshall, Henry, McWilliams, Annette, Zalcberg, John R., Caruana, Michael and Canfell, Karen (2022). Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes. British Journal of Cancer, 128 (1), 91-101. doi: 10.1038/s41416-022-02026-8

Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes

2022

Journal Article

Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation

Dunlop, Kate L. A., Marshall, Henry M., Stone, Emily, Sharman, Ashleigh R., Dodd, Rachael H., Rhee, Joel J., McCullough, Sue and Rankin, Nicole M. (2022). Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation. PLoS One, 17 (9) e0275361, 1-16. doi: 10.1371/journal.pone.0275361

Motivation is not enough: A qualitative study of lung cancer screening uptake in Australia to inform future implementation

Funding

Current funding

  • 2025 - 2030
    CuRE Centre of Research Excellence to prevent and detect curable lung cancer
    NHMRC Centres of Research Excellence
    Open grant
  • 2025 - 2028
    Fidelity, feasibility, and acceptability of a novel wearable nicotine sensor in clinical practice
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant
  • 2023 - 2025
    Plasma and serum miRNAs for lung cancer screening
    Prince Charles Hospital Foundation
    Open grant
  • 2023 - 2027
    'Max Up' Trial - Maximising uptake of lung cancer screening and smoking cessation outcomes
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2021 - 2026
    ACRF Lung Cancer Screening CENTRE OF EXCELLENCE (LUSCE)
    Australian Cancer Research Foundation
    Open grant
  • 2021 - 2026
    Smoking cessation chatbot: Prototype testing and feedback from consumers, clinicians and academics
    Prince Charles Hospital Foundation
    Open grant
  • 2021 - 2027
    Lung cancer screening for early detection
    NHMRC MRFF EPCDR - Improving Diagnosis in Cancers with Low Survival Rates
    Open grant
  • 2020 - 2025
    Enhancing smoking cessation with an innovative mobile health avatar
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2021 - 2024
    Comparison of DXA to CT-based methods (L1HU and QCT) to detect osteoporosis and predict vertebral fracture in lung cancer screening participants (sub-study of the International Lung Screening Trial)
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2025
    Protein Panel in The International Lung Screen Trial (PP-ILST)
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2018 - 2019
    The socioemotional dimensions of lung cancer screening and smoking cessation (a substudy of the international lung screen trial)
    Prince Charles Hospital Foundation
    Open grant
  • 2016 - 2023
    ACRF Centre for Lung Cancer Early Detection
    Australian Cancer Research Foundation
    Open grant

Supervision

Availability

Associate Professor Henry Marshall is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • Lung cancer screening

    Multiple clinical trials of lung cancer screening

  • Smoking cessation

    Clinical trials of smoking cessation

  • Artificial intelligence - medical imaging

    Analysis of computed tomography scans

  • Lung cancer biomarkers

    For early detection

  • Artificial intelligence - smoking cessation smartphone app

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor Henry Marshall's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au